Trace Genomics
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$4.0m | Seed | ||
$2.0m | Convertible | ||
$13.0m | Series A | ||
$3.0m Valuation: $65.0m | Early VC | ||
N/A | $17.2m | Series B | |
N/A | Convertible | ||
$8.1m | Series B | ||
* | $10.5m Valuation: $86.0m | Series B | |
Total Funding | €52.5m |
Related Content
Recent News about Trace Genomics
EditTrace Genomics leverages advanced soil genomics, soil science, and machine learning to provide comprehensive insights into soil biology, physical properties, and chemistry. Serving agronomists, farmers, and agricultural retailers, the company operates in the precision agriculture market. Trace Genomics' business model revolves around offering detailed soil analysis and actionable insights, enabling clients to optimize crop yields and manage soil health effectively. Revenue is generated through subscription-based services and partnerships with agricultural retailers and next-generation product companies. The company stands out by delivering a complete understanding of soil conditions, which helps in making informed decisions for economic and ecosystem benefits.
Keywords: soil genomics, precision agriculture, machine learning, soil health, crop yield optimization, agronomists, farmers, agricultural retailers, soil analysis, ecosystem benefits.